In vivo bioluminescence imaging of inducible nitric oxide synthase gene expression in vascular inflammation

Molecular Imaging and Biology

Volumn 13, Issue 6, 2011, Pages 1061-1066

  Terashima, Masahiro ^a   Ehara, Shoichi ^a   Yang, Eugene ^b   Kosuge, Hisanori ^a   Tsao, Philip S ^a   Quertermous, Thomas ^a   Contag, Christopher H ^a   McConnell, Michael V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Bioluminescence; Inducible nitric oxide synthase; Macrophages; Vascular inflammation

Indexed keywords

LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CAROTID ARTERY; CELL INFILTRATION; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HISTOPATHOLOGY; IN VIVO STUDY; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; MACROPHAGE MIGRATION; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STREPTOZOCIN DIABETES; UPREGULATION; VASCULITIS;

ANIMALS; CAROTID ARTERY, COMMON; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMAGING, THREE-DIMENSIONAL; INFLAMMATION; LUCIFERASES; LUMINESCENT MEASUREMENTS; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; STAINING AND LABELING;

ANIMALIA; MURINAE; MUS;

EID: 84855697331     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0451-5     Document Type: Article

References (23)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874 (Pubitemid 36019640)
2. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47:C13-C18
3. Wilcox JN, Subramanian RR, Sundell CL et al (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17:2479-2488 (Pubitemid 28015984)
4. Hunter GC,Henderson AM,Westerband A et al (1999) The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque. J Vasc Surg 30:36-49, discussion 50
5. Behr-Roussel D, Rupin A, Sansilvestri-Morel P, Fabiani JN, Verbeuren TJ (2000) Histochemical evidence for inducible nitric oxide synthase in advanced but non-ruptured human atherosclerotic carotid arteries. Histochem J 32:41-51 (Pubitemid 30204155)
6. Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235-260 (Pubitemid 35217421)
7. Zhang N, Weber A, Li B et al (2003) An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice. J Immunol 170:6307-6319 (Pubitemid 36682617)
8. Lichtman AH, Clinton SK, Iiyama K et al (1999) Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 19:1938-1944 (Pubitemid 29379925)
9. Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus. Science 193:415-417
10. Kumar A, Lindner V (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17:2238-2244 (Pubitemid 28057127)
11. Tanaka M, Swijnenburg RJ, Gunawan F et al (2005) In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation 112:I105-I110 (Pubitemid 41266660)
12. Davies JR, Rudd JH, Weissberg PL, Narula J (2006) Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 47:C57-C68
13. Jaffer FA, Nahrendorf M, Sosnovik D et al (2006) Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 5:85-92 (Pubitemid 44106143)
14. Tawakol A, Migrino RQ, Bashian GG et al (2006) In vivo 18 Ffluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48:1818-1824 (Pubitemid 44648622)
15. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103:415-422 (Pubitemid 32105982)
16. Hyafil F, Cornily JC, Feig JE et al (2007) Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 13:636-641 (Pubitemid 46828482)
17. Detmers PA, Hernandez M, Mudgett J et al (2000) Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 165:3430-3435
18. Hayashi T, Matsui-Hirai H, Fukatsu A et al (2006) Selective iNOS inhibitor, ONO1714 successfully retards the development of highcholesterol diet induced atherosclerosis by novel mechanism. Atherosclerosis 187:316-324 (Pubitemid 43963030)
19. Boyle JJ (2005) Macrophage activation in atherosclerosis: Pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3:63-68 (Pubitemid 40089528)
20. Harmon KJ, Couper LL, Lindner V (2000) Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 156:1741-1748 (Pubitemid 30646711)
21. Korshunov VA, Berk BC (2004) Strain-dependent vascular remodeling: The "Glagov phenomenon" is genetically determined. Circulation 110:220-226 (Pubitemid 38924591)
22. Kunjathoor VV, Wilson DL, LeBoeuf RC (1996) Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767-1773 (Pubitemid 26105486)
23. Hayek T, Hussein K, Aviram M et al (2005) Macrophage foam-cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose. Atherosclerosis 183:25-33 (Pubitemid 41416818)